Last reviewed · How we verify
NCT07265219: PROBTEC
PROBTEC Program to Manage Problematic Technology Use in Adolescents
NA trial testing PROBTEC Management Program in Health Promotion Model (HPM) in 200 participants. Completed in 29 November 2023.
12 May 2023
Quick facts
| Lead sponsor | Karabuk University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 200 |
| Start date | 27 March 2023 |
| Primary completion | 12 May 2023 |
| Estimated completion | 29 November 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- PROBTEC Management Program
Conditions studied
- Health Promotion Model (HPM) — all drugs for Health Promotion Model (HPM) →
- Randomized Controlled Trial — all drugs for Randomized Controlled Trial →
- Technology Use — all drugs for Technology Use →
- Adolescents — all drugs for Adolescents →
Sponsor
Karabuk University
Who can join
Adults 14 to 15, any sex, with Health Promotion Model (HPM) or Randomized Controlled Trial. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Excessive engagement with digital devices among adolescents has become a significant public health concern, contributing to reduced physical activity and associated health risks. This study assessed the impact of the PROBTEC Management Program-an intervention structured around the Health Promotion Model-on technology-related behaviors and activity levels in adolescents. A randomized controlled trial was implemented in 10 public middle schools in Türkiye with a total sample of 200 students aged 14-15 years. Schools were allocated to either the intervention or control condition using cluster randomization. The intervention spanned six weeks and combined health education sessions, guided physical activity practices, and parent-focused components. Measures were obtained at four time points (baseline, 1 week, 3 months, 6 months) using validated questionnaires, pedometer-based step counts, and the International Physical Activity Questionnaire. Data were analyzed using repeated measures statistical techniques and standardized effect size calculations. Participants receiving the PROBTEC intervention demonstrated notable improvements over time. Compared with controls, the intervention group exhibited reduced indicators of problematic technology engagement and perceived exercise barriers, alongside increases in perceived exercise benefits, physical activity self-efficacy, and total MET scores. Findings indicate that the PROBTEC Management Program supports positive behavioral changes by reducing unhealthy technology use and encouraging more active lifestyles among adolescents. The sustained effects observed across the 6-month follow-up period suggest that this school-based, theory-driven model may be a practical and scalable strategy for adolescent health promotion
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07265219
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Karabuk University trials
Trials by the same sponsor.
- NCT07530692 — Video-Supported Flipped Learning for Episiotomy Training in Midwifery Students · NA · not yet recruiting
- NCT07495475 — Mobile App-Supported Exercise Program For Mechanical Low Back Pain · NA · not yet recruiting
- NCT07473245 — Educational Models for Tobacco Exposure Awareness · NA · not yet recruiting
- NCT07389395 — Grastion and Percussion Therapy · NA · not yet recruiting
- NCT07368387 — QR Code-Based Preoperative Education for Cesarean Birth: Anxiety, Pain, and Comfort · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07265219 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karabuk University
- Last refreshed: 4 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07265219.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing